General Statement of Disclosure:
OTHER FINANCIAL BENEFIT: Mass tort against Pfizer on behalf of healthy women who developed diabetes on Lipitor(SIGNIFICANT)
OTHER FINANCIAL BENEFIT: Mass tort against Pfizer on behalf of healthy women who developed diabetes on Lipitor(SIGNIFICANT)
© 2024 American College of Cardiology Foundation. All rights reserved.